Skip to main content

Published locations for Adding ibrutinib to chemoimmunotherapy improves outcomes of relapsed CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding ibrutinib to chemoimmunotherapy improves outcomes of relapsed CLL

User login

  • Reset your password
  • /content/adding-ibrutinib-chemoimmunotherapy-improves-outcomes-relapsed-cll
  • /oncologypractice/article/100063/rare-diseases/adding-ibrutinib-chemoimmunotherapy-improves-outcomes
  • /hematology-oncology/article/100063/rare-diseases/adding-ibrutinib-chemoimmunotherapy-improves